TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RAPP

Rapport Therapeutics, Inc.

Healthcare · Biotechnology

33.90$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement RAPP
Line item 2022 2023 2024 2025
– – – –
– +646.7% +649.1% +21.2%
– – – –
– +207.2% +117.6% +55.6%
– +498.9% +170.4% +37.0%
– +249.5% +129.6% +50.6%
– – – –
– -100.0% – –
– – – –
– – – –
– – – –
– – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?